ALKBH1 and hepatocellular carcinoma: Specifically, the overexpression of ALKBH1 is negatively correlated with the overall survival rate of HCC, indicating that ALKBH1 may be regarded as a pivotal poor prognosis marker for HCC, but further research is needed (Ma et al., 2019).